Table: Wakamoto Pharm -2022/23 parent results

Wakamoto Pharmaceutical

15/05/2023 07:00

May 15 (Reuters)- 
          Wakamoto Pharmaceutical Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2023    Mar 31, 2022   Mar 31, 2024     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           8.66            8.38                                 
               (+3.3 pct)                                              
  Operating      141 mln       loss 13 mln                             
  Recurring      242 mln         72 mln                                
              (+235.7 pct)                                             
  Net            138 mln         238 mln                               
               (-42.0 pct)                                             
  EPS           3.98 yen        6.87 yen                               
  Ann Div       3.00 yen           NIL                                 
  -Q2 Div          NIL             NIL                                 
  -Q4 Div       3.00 yen           NIL                                 
  
  NOTE - Wakamoto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T